<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02154750</url>
  </required_header>
  <id_info>
    <org_study_id>130663</org_study_id>
    <nct_id>NCT02154750</nct_id>
  </id_info>
  <brief_title>AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals</brief_title>
  <acronym>AV Delay</acronym>
  <official_title>Evaluation of AV Delay Optimization vs. Intrinsic Conduction in Patients With Long PR Intervals Receiving Dual Chamber Pacemakers for Symptomatic Bradycardia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, prospective clinical trial to determine the effects of two different
      pacemaker atrioventricular delay (AV delay) settings on heart function in patients with dual
      chamber pacemakers implanted for symptomatic bradycardia with long PR intervals (delayed
      conduction between upper and lower chambers of the heart). The study will compare a long,
      fixed AV delay (standard) with an optimized AV delay for each individual using
      echocardiography (experimental).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac pacing is the only effective treatment for symptomatic sinus node dysfunction. Most
      patients with preserved left ventricular function receive dual chamber pacemakers; however,
      right ventricular pacing can have detrimental effects on left ventricular function due to the
      abnormal electrical and mechanical activation pattern of the ventricles.

      Many patients receiving dual chamber pacemakers for symptomatic bradycardia have prolonged
      intrinsic AV conduction (first degree AV block), and as a result, will receive a significant
      amount of ventricular pacing if programmed at physiologic AV intervals. As an alternative,
      many pacemakers can be programmed to minimize ventricular pacing at the expense of allowing
      longer AV delays. However, these long AV delays may not be physiologic and may also lead to
      reduced cardiac output. At present the standard of care is either to program the pacemaker at
      an physiologic &quot;natural&quot; AV delay of about 160 msec or to program the pacemaker with a long
      AV delay to minimize ventricular pacing.

      The main scientific questions being addressed in this study are to evaluate the acute and
      chronic effects on cardiac output, functional status, sense of well-being, and cardiac
      remodeling of a long AV delay allowing for intrinsic conduction as compared to an
      echocardiographically optimized AV delay during dual chamber pacing.

      Patients enrolled in the trial will complete a run-in period of two weeks prior to
      randomization in which pacemakers will be programmed with a long-fixed AV delay to allow
      intrinsic conduction and minimize ventricular pacing (standard). At two weeks, patients will
      receive a baseline echocardiogram. To determine optimal AV delay, all patients will undergo
      echocardiographic analysis at varying AV delays. Optimal AV delay will be defined as the AV
      delay associated with the largest average aortic Doppler velocity time integral (VTI). Then,
      patients will be randomized to either the short, optimized (experimental) or long, fixed
      (standard) AV delay groups. To assess functional status and sense of well-being, patients
      will complete a six minute walk test and Short Form-36 Medical Outcomes Study Questionnaire.
      Patients return to clinic for another study visit at 6 months and repeat research procedures,
      including baseline echocardiogram, questionnaire, and 6 minute walk test.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cardiac output determined by echocardiography</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in functional status determined by 6 minute walk.</measure>
    <time_frame>6 months</time_frame>
    <description>Measure distance walked in 6 minutes in meters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in sense of well being as determined by Short Form - 36 Medical Outcomes Study Questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>Sense of well being score determined by answers to questions on Short Form - 36 questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Atrioventricular Block</condition>
  <condition>Sick Sinus Syndrome</condition>
  <condition>Symptomatic Bradycardia</condition>
  <condition>Cardiac Arrhythmia</condition>
  <arm_group>
    <arm_group_label>Long, fixed AV delay</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pacemaker will be set to a long, fixed AV delay to minimize ventricular pacing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Short, optimized AV delay</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pacemaker will be set to the AV delay that produces the greatest cardiac output in echocardiography for each patient enrolled</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Long, fixed AV delay</intervention_name>
    <description>Pacemaker will be set to a long, fixed AV delay to minimize ventricular pacing</description>
    <arm_group_label>Long, fixed AV delay</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Short, optimized AV delay</intervention_name>
    <description>Pacemaker will be set to the AV delay that produces the greatest cardiac output in echocardiography for each patient enrolled.</description>
    <arm_group_label>Short, optimized AV delay</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patient population: Individuals with 1st degree atrioventricular (AV) block who have
        received a dual chamber pacemaker for symptomatic bradycardia.

        Inclusion Criteria:

          1. Patients greater than 18 years of age

          2. Patients with symptomatic sinus bradycardia

          3. Patients who meet standard indications for dual chamber pacemaker implantation

          4. Patients who have 1st degree AV block determined by PR interval &gt; 200ms

        Exclusion Criteria:

          1. Patients with complete or high grade AV block

          2. Patients who are unable to complete dual chamber pacemaker implantation for any reason

          3. Patients with congestive heart failure determined by a Left Ventricular Ejection
             Fraction &lt; 45%

          4. Patients with persistent atrial fibrillation

          5. Sustained premature ventricular contractions (PVCs), premature atrial contractions
             (PACs), atrial flutter, or other heart conditions that may interfere with
             echocardiography measurements

          6. Patients who are pregnant

          7. Patients with Paroxysmal Atrial Fibrillation that have had an episode(s) within 30
             days of consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory K Feld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSD Electrophysiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maylene Alegre, BHS</last_name>
    <phone>858-246-2406</phone>
    <email>malegre@ucsd.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCSD Sulpizio Cardiovascular Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica A Hunter, BHS</last_name>
      <phone>858-246-2402</phone>
      <email>j2hunter@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory K Feld, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm. 2004 Nov;1(5):562-7.</citation>
    <PMID>15851220</PMID>
  </reference>
  <reference>
    <citation>Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol. 2009 Aug 25;54(9):764-76. doi: 10.1016/j.jacc.2009.06.006. Review.</citation>
    <PMID>19695453</PMID>
  </reference>
  <reference>
    <citation>Iliev II, Yamachika S, Muta K, Hayano M, Ishimatsu T, Nakao K, Komiya N, Hirata T, Ueyama C, Yano K. Preserving normal ventricular activation versus atrioventricular delay optimization during pacing: the role of intrinsic atrioventricular conduction and pacing rate. Pacing Clin Electrophysiol. 2000 Jan;23(1):74-83.</citation>
    <PMID>10666756</PMID>
  </reference>
  <reference>
    <citation>Sweeney MO, Ellenbogen KA, Tang AS, Whellan D, Mortensen PT, Giraldi F, Sandler DA, Sherfesee L, Sheldon T; Managed Ventricular Pacing Versus VVI 40 Pacing Trial Investigators. Atrial pacing or ventricular backup-only pacing in implantable cardioverter-defibrillator patients. Heart Rhythm. 2010 Nov;7(11):1552-60. doi: 10.1016/j.hrthm.2010.05.038. Epub 2010 Jun 4.</citation>
    <PMID>20685401</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Gregory Kent Feld</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Atrioventricular delay</keyword>
  <keyword>AV delay</keyword>
  <keyword>Pacemaker</keyword>
  <keyword>Sick Sinus Syndrome</keyword>
  <keyword>Bradycardia</keyword>
  <keyword>PR interval</keyword>
  <keyword>Atrioventricular block</keyword>
  <keyword>AV block</keyword>
  <keyword>Echocardiography</keyword>
  <keyword>Arrhythmia</keyword>
  <keyword>AV optimization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Sick Sinus Syndrome</mesh_term>
    <mesh_term>Atrioventricular Block</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

